• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于植入式除颤器植入的反复诱发心室颤动期间的诱发电位监测。

Evoked potential monitoring during repeatedly induced ventricular fibrillation for internal defibrillator implantation.

作者信息

Haussmann R, Polarz H, Rauch H, Graf B, Lang J, Fleischer F, Martin E, Saggau W

机构信息

Department of Anesthesiology, University of Heidelberg, Germany.

出版信息

J Cardiothorac Vasc Anesth. 1994 Feb;8(1):61-3. doi: 10.1016/1053-0770(94)90014-0.

DOI:10.1016/1053-0770(94)90014-0
PMID:8167288
Abstract

Repeated induction of ventricular fibrillation (VF) with circulatory compromise during implantable cardioverter defibrillator (ICD) testing may cause cerebral injury. To test this hypothesis, somatosensory evoked potentials (SEP), a more sensitive marker of injury, were recorded in patients (N = 10) undergoing ICD implantation. SEP were recorded before induction of anesthesia, after induction of anesthesia, before and at several times following induction of VF. Possible modifying factors of the SEP measurements such as anesthetic application, blood pressure, body temperature, and hematocrit remained constant throughout the operations. Central conduction time was unaffected by ICD defibrillation testing. Amplitude of SEP primary complexes was transiently reduced at 34.9% (P < 0.01) by defibrillation testing, but returned to control within 10 minutes after testing. It is concluded that while ICD defibrillation testing may produce transient changes in SEP, there is no evidence of residual cerebral injury.

摘要

在植入式心脏复律除颤器(ICD)测试期间,反复诱发伴有循环功能障碍的心室颤动(VF)可能会导致脑损伤。为了验证这一假设,对接受ICD植入术的患者(N = 10)记录体感诱发电位(SEP),这是一种更敏感的损伤标志物。在麻醉诱导前、麻醉诱导后、VF诱导前及诱导后的几个时间点记录SEP。在整个手术过程中,SEP测量的可能影响因素,如麻醉应用、血压、体温和血细胞比容保持恒定。中央传导时间不受ICD除颤测试的影响。除颤测试使SEP主要复合波的幅度短暂降低了34.9%(P < 0.01),但在测试后10分钟内恢复至对照水平。结论是,虽然ICD除颤测试可能会使SEP产生短暂变化,但没有证据表明存在残留脑损伤。

相似文献

1
Evoked potential monitoring during repeatedly induced ventricular fibrillation for internal defibrillator implantation.用于植入式除颤器植入的反复诱发心室颤动期间的诱发电位监测。
J Cardiothorac Vasc Anesth. 1994 Feb;8(1):61-3. doi: 10.1016/1053-0770(94)90014-0.
2
Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.法国植入式心脏复律除颤器植入术中日常医疗实践中的除颤测试:来自 LEADER 注册研究的分析。
Arch Cardiovasc Dis. 2013 Nov;106(11):562-9. doi: 10.1016/j.acvd.2013.07.002. Epub 2013 Nov 4.
3
High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.植入式除颤器电击后心室复极的高度离散预示着心室颤动的诱发以及除颤失败。
J Am Coll Cardiol. 2000 Feb;35(2):422-7. doi: 10.1016/s0735-1097(99)00579-3.
4
Development of ventricular fibrillations with different characteristics in the local electrocardiogram: large and small amplitude of activation, and its implication for implantable cardioverter defibrillator treatment.局部心电图中具有不同特征的心室颤动的发生:激活幅度的大小及其对植入式心脏复律除颤器治疗的意义。
Jpn Circ J. 1999 Dec;63(12):1007-10. doi: 10.1253/jcj.63.1007.
5
Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.多中心自动除颤器植入试验(MADIT)II患者中心室性心律失常可诱导性对后续室性心动过速或心室颤动的预测价值。
J Am Coll Cardiol. 2006 Jan 3;47(1):98-107. doi: 10.1016/j.jacc.2005.08.049. Epub 2005 Dec 15.
6
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试:多中心ASSURE研究(心律失常单次电击除颤阈值测试与易损性上限:植入式心脏复律除颤器植入的风险降低评估)结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
7
Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.皮下植入式心脏复律除颤器放置的麻醉管理:单中心经验。
J Clin Anesth. 2016 Jun;31:53-9. doi: 10.1016/j.jclinane.2015.11.009. Epub 2016 Mar 22.
8
Hemodynamic changes due to intraoperative testing of the automatic implantable cardioverter defibrillator: implications for anesthesia management.植入式自动心脏复律除颤器术中测试引起的血流动力学变化:对麻醉管理的影响。
J Cardiothorac Vasc Anesth. 1993 Aug;7(4):442-7. doi: 10.1016/1053-0770(93)90167-j.
9
Implantable cardioverter-defibrillator. Evaluation of clinical neurologic outcome and electroencephalographic changes during implantation.植入式心脏复律除颤器。植入过程中临床神经学结局及脑电图变化的评估。
J Thorac Cardiovasc Surg. 1995 Mar;109(3):565-73. doi: 10.1016/S0022-5223(95)70290-3.
10
Is defibrillation testing safe?除颤测试安全吗?
Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 2):1899-904. doi: 10.1111/j.1540-8159.1991.tb02787.x.

引用本文的文献

1
Neuromonitoring in defibrillation threshold testing. A comparison between EEG, near-infrared spectroscopy and jugular bulb oximetry.
J Clin Monit. 1997 Sep;13(5):303-7. doi: 10.1023/a:1007323823806.